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I
nflammatory myofibroblastic tumor (IMT) consisting of a
spindle cell proliferation admixed with an inflammatory
component is an uncommon mesenchymal lesion that
can arise in multiple anatomic locations1,2. Because of its het-
erogenic histologic appearance, different synonyms have
been used throughout the literature, including inflammatory
Fig. 1 Fig. 2
Fig. 1 Radiograph showing destruction of the right pedicle of T12. Fig. 2 Axial CT of the lesion with a minimal marginal sclerosis.
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pseudotumor, fibromyxoid lesion, pseudosarcomatous myofi-
broblastic tumor, and plasma cell granuloma2. Although IMTs
have been considered benign proliferation of myofibroblasts,
they have potential for recurrence, persistent local growth3,
and local aggressive behavior2,4. Their malignant potential is
controversal5. The rare entity of multilocality has been de-
scribed6,7 and might even be interpreted as metastatic oc-
currence8. Although very rare, even paraneoplastic symptoms
have been attributed to IMT9. While IMTs seem to localize
predominantly in the viscera (e.g., lung) and soft tissue (e.g.,
mesentery and omentum)2, they arise very infrequently in
bone. Their occurrence has been reported in cranial bones10-12,
long bones13,14, the sacrum9, and the iliac bone15. IMTs in the
spinal system are also reported16-19, but primary occurrence
in a vertebral body is extremely rare1. Roberts et al. described
a case of an IMTof the T10 vertebra compressing the thecal
sac and involving the paravertebral muscles20, but it was
unclear whether the IMToriginated from the vertebral bone
or from the surrounding soft tissues. We present a rare case
of a localized IMT in the T12 vertebra, and we describe the
difficulties involved in histological diagnosis and treat-
ment. The patient was informed that data concerning the
case would be submitted for publication, and she provided
consent.
Fig. 3
Fig. 4
Fig. 3 Core biopsy of the vertebral mass showing spindle cell
proliferation with a few mitotic figures (black arrow) and some
lymphocytes (white arrows) (hematoxylin and eosin stain, original
magnification 100·). Inset (upper right) demonstrates focal
immunohistochemical expression of smooth muscle actin (brown
reaction product; original magnification 100·). SMA = smooth
muscle actin. Fig. 4 The dural sac is retracted to the left; two
straight osteotomes were used for sagittal osteotomy of the
vertebral body. Fig. 5
An axial-cut section of the resected specimen with tumormass (white star)
(hemorrhagic after the core biopsies) in the pedicle, with infiltration of
the vertebral body and costovertebral angle. The black star indicates
the spinal canal; the arrow indicates the rib.
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Case Report
Athirty-seven-year-old woman presented with persistentand localized constant pain at the right costovertebral
joint of the T12 vertebra. The medical history and clinical
findings were normal. The radiographs showed destruction
of the right pedicle of T12 (Fig. 1). Magnetic resonance imaging
(MRI) revealed an expansive osteolytic mass (35 · 26 · 20 mm)
in T12, which affected the right posterolateral aspect of the
vertebral body, the right pedicle, the lamina, the inferior artic-
ular process, and the transverse process. Computed tomography
(CT) showed slight sclerosis of the margins of the osteolysis,
indicating a slow-growing lesion (Fig. 2). Two subsequent
CT-guided core biopsies showed similar results and revealed
a moderately cellular spindle cell proliferation with slight atypia,
accompanied by some inflammatory cells (mostly lymphocytes
and plasma cells) (Fig. 3). Immunohistochemical staining re-
vealed focal positivity for smooth muscle actin21 (clone 1A4,
dilution 1:20000; Sigma-Aldrich, Buchs, Switzerland) and cy-
tokeratin (AE1/AE3, dilution 1:50; DAKO Schweiz AG, Baar,
Switzerland) (Fig. 3). All other markers, including thyroid tran-
scription factor 1, estrogen and progesterone receptors, and
the CDX2 protein, as well as melanocytic markers, the remaining
myogenic and neuroendocine markers, and epithelial mem-
brane antigen, activating receptor-like kinase 1 (ALK1), CD34,
CD117, and CD21, were negative. There were few mitoses,
and the proliferation index, as measured by MIB-1 staining
(clone 30-9, prediluted; Roche Diagnostics [Schweiz] AG,
Rotkreuz, Switzerland), was low (below 5%). There was no os-
teoid or cartilage matrix production. Staging procedure, includ-
ing mammography and ultrasound of the breasts, CT, MRI, and
positron emission tomography (PET)-CT, as well as gastroscopy
and colonoscopy, failed to provide evidence of any other tumor
manifestations, a primary tumor, or metastatic disease.
Surgical Technique
Through a midline skin incision, the T11 to L1 levels were ex-
posed. On the right side, the lamina of T12 was not exposed, and
a layer of muscle covering the lamina was left. Pedicle screws
were placed in T11 and L1. Osteotomies were performed through
the facet joints at T11-T12 and T12-L1 on the right side. After
a right-sided costotransversectomy of T12, the lateral and
anterior surfaces of the T12 body were exposed by blunt dis-
section of the pleura. A malleable retractor was inserted from
the right side to the anterior surface of the vertebral body,
displacing the aorta anteriorly; then, incisions were made into
the intervertebral discs at T11-T12 and T12-L1. The T12 nerve
root on the right side was sacrificed because of its proximity
to the mass in the foramen. After the laminectomy at T11, the
dural sac was retracted to the left, and a sagittal osteotomy at
the midline of the T12 vertebral body was performed from
posterior to anterior with use of ordinary straight osteotomes
(Fig. 4). Then, the specimen, including the right half of the
Fig. 6
Figs. 6-A and 6-B Imaging after reconstruction. Fig. 6-A An axial CT shows the extent of the partial vertebrectomy. Fig. 6-B A radiograph demonstrates the
reconstruction with the titanium mesh cage and pedicle screw instrumentation on the right side.
Fig. 7
The resection specimen showed areas of more loosely arranged bland
spindle cells with focal collections (stars) of inflammatory cells (lympho-
cytes and granulocytes) (hematoxylin and eosin stain, original magnification
200·).
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vertebral body with the upper and lower end plates, the pedicle,
the articular facets, the transverse process, and part of the at-
tached rib, was removed en bloc (Fig. 5). Reconstruction was
achieved with a titanium mesh cage on the right side that was
filled with autologous bone from the iliac crest (Fig. 6). The
patient’s postoperative course was uneventful. Weight-bearing
and walking without bracing began on the first postoperative
day.
At the six-week follow-up, the patient was asymptomatic
and was reintegrated into normal daily life. Adjuvant therapy
was not instituted. At the six-month follow-up, there was no
evidence of a recurrence of the lesion on MRI or CT. At the
twelve-month follow-up, the patient was pain-free, and there
was evidence of solid fusion without any signs of recurrence
on a repeat CT.
Histological Analysis
Histologically, the tumor consisted of monomorphic spindle
cells arranged vaguely in loose fascicles, with focal areas of
edematous matrix (Fig. 7) and infiltrates of inflammatory cells
(lymphocytes, plasma cells, and granulocytes). The main tu-
mor mass (Fig. 5) was found in the osseous structures of the
pedicle, with spreading in the vertebral body; there was also
infiltration of the soft tissue of the costovertebral angle. No
osteoid production or intralesional cartilage was found. The
mitotic figures were scarce (less than two in ten high-power
fields). The tumor cells showed myofibroblastic phenotype
with slender cytoplasm and oval nuclei with small nucleoli.
In concordance with the preceding biopsy, focal expression
of smooth muscle actin and cytokeratin was found, while all
other markers, including ALK1, remained negative. Fluo-
rescence in situ hybridization (FISH) failed to demonstrate
the rearrangement of the ALK1 gene (Fig. 8). IMT was di-
agnosed. No tumor was found within 3 mm of the resection
margin.
Discussion
An IMT consisting of a spindle cell proliferation admixedwith an inflammatory component is an uncommon me-
senchymal lesion that can arise in multiple anatomic locations2.
We present a rare case of a localized, ALK1-FISH negative IMT
in the T12 vertebra. Once considered a reactive process, an IMT
is currently classified as a neoplastic lesion22; rearrangement
of the ALK1 gene, located on chromosome region 2p23, and
coding for a tyrosine kinase receptor member of the insulin
growth factor receptor superfamily are found in approximately
50% of cases, indicating a specific genetic background for this
entity. The availability of ALK1 inhibitors (e.g., crizotinib)
may be a therapeutic option in ALK1-positive aggressive
IMTs23. The IMT case described in our report did not show
the rearrangement of the ALK1 gene with the FISH technique
(Fig. 8).
Because IMTs are very rare and manifest with a wide
range of presentations depending on location and extent, no
established guidelines exist regarding the best treatment
modality. An overall recurrence rate as high as 8% to 25%2,22
has been reported with incomplete resection, and removal
with wide margins is recommended2. Although the role of
adjunctive treatment is largely unknown, it has been suggested
that adjuvant chemotherapy be considered in conjunction
with radiation therapy if complete resection cannot be ach-
ieved2. This case report illustrates the difficulties in histological
diagnosis of IMTs, as well as the successful surgical treatment
with complete en bloc resection. At the one-year follow-up,
the patient was free of symptoms and there was no evidence
of recurrence on repeat CT. In addition, histology showed
that no tumor was found within 3 mm of the resection
margin. Therefore, recurrence is not expected, and the ne-
cessity for additional follow-up radiographs is unknown and
debatable. n
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Fig. 8
The FISH technique for the ALK1 gene showed one to two exclusively fused
green and red signals in the nuclei of the tumor cells, indicating the lack of
the rearrangement of this gene in the tumor tissue.
4
JBJS CASE CONNECTOR
VOLUME 3 d NUMBER 2 d MAY 8, 2013
INTRAOSSEOUS INFLAMMATORY MYOF IBROBLAST IC TUMOR
OF THE TWELFTH THORACIC VERTEBRA
References
1. Chang H, Park JB, Kim KW. Intraosseous calcifying pseudotumor of the axis: a
case report. Spine (Phila Pa 1976). 2000 Apr 15;25(8):1036-9.
2. Kovach SJ, Fischer AC, Katzman PJ, Salloum RM, Ettinghausen SE, Madeb R,
Koniaris LG. Inflammatorymyofibroblastic tumors. J Surg Oncol. 2006Oct 1;94(5):385-91.
3. Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myo-
fibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohis-
tochemical study of 84 cases. Am J Surg Pathol. 1995 Aug;19(8):859-72.
4. Hedlund GL, Navoy JF, Galliani CA, Johnson WH Jr. Aggressive manifestations of
inflammatory pulmonary pseudotumor in children. Pediatr Radiol. 1999 Feb;29(2):112-6.
5. Dahabreh J, Zisis C, Arnogiannaki N, Katis K. Inflammatory pseudotumor: a
controversial entity. Eur J Cardiothorac Surg. 1999 Dec;16(6):670-3.
6. Ishihara M, Izumoto S, Iwatsuki K, Yoshimine T. Immunohistochemical study
of multiple inflammatory pseudotumors with both brain and spinal cord
involvement—case report. Neurol Med Chir (Tokyo). 2010;50(3):246-50.
7. Sasagawa Y, Akai T, Itou S, Iizuka H. Multiple intraosseous inflammatory myofi-
broblastic tumors presenting with an aggressive clinical course: case report. Neu-
rosurgery. 2011 Oct;69(4):E1010-5; discussion E1015-6.
8. Petridis AK, Hempelmann RG, Hugo HH, Eichmann T, Mehdorn HM. Metastatic
low-grade inflammatory myofibroblastic tumor (IMT) in the central nervous system of
a 29-year-old male patient. Clin Neuropathol. 2004 Jul-Aug;23(4):158-66.
9. Allanore Y, Pham XV, Clerc DA, Menke`s CJ, Kahan A. Sacral inflammatory
pseudotumor revealed by paraneoplastic syndrome. Rheumatol Int. 2004
May;24(3):166-8. Epub 2003 Dec 02.
10. Ghosal N, Roy R, Reddy K, Hegde AS. Inflammatory myofibroblastic tumor
parieto-occipital bone. Indian J Pathol Microbiol. 2010 Jul-Sep;53(3):529-31.
11. Papanikolaou V, Nikitakis N, Marinakis K, Bousiotou A, Xenelis I. Inflammatory
myofibroblastic tumor of the temporal bone. Otol Neurotol. 2012 Jan;33(1):e5-6.
12. Santaolalla-Montoya F, Eren˜oC, Zabala A, Carrasco A,Martı´nez-Ibargu¨en A, Sa´nchez-
Ferna´ndez JM. Inflammatory myofibroblastic tumor of the temporal bone: a histologically
nonmalignant lesion with fatal outcome. Skull Base. 2008 Sep;18(5):339-43.
13. Chen J, Li H, Yang Z, Liu Q, Gao M, Jiang X, Cai Z, Liang B, Jiang Y. Inflammatory
myofibroblastic tumor of bone: two cases occurring in long bone. Skeletal Radiol.
2011 Jan;40(1):117-22. Epub 2010 Jul 22.
14. Sciot R, Dal Cin P, Fletcher CD, Hernandez JM, Garcia JL, Samson I, Ramos L,
Brys P, Van Damme B, Van den Berghe H. Inflammatory myofibroblastic tumor of
bone: report of two cases with evidence of clonal chromosomal changes. Am J Surg
Pathol. 1997 Oct;21(10):1166-72.
15. Watanabe K, Tajino T, Sekiguchi M, Suzuki T. Inflammatory myofibroblastic
tumor (inflammatory fibrosarcoma) of the bone. Arch Pathol Lab Med. 2000
Oct;124(10):1514-7.
16. BoutarbouchM, Arkha Y, Rifi L, Derraz S, El Ouahabi A, El Khamlichi A. Intradural
cervical inflammatory pseudotumor mimicking epidural hematoma in a pregnant
woman: case report and review of the literature. Surg Neurol. 2008 Mar;69(3):302-
5. Epub 2007 Sep 04.
17. Seol HJ, Kim SS, Kim JE, Lee SH, Won JY. Inflammatory pseudotumor in the
epidural space of the thoracic spine: a case report and literature review of MR
imaging findings. AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2667-70.
18. Yoon SH, Kim KJ, Chung SK, Kim HJ, Choe G, Chung SB, Jin YJ. Inflammatory
myofibroblastic tumor in the intradural extramedullary space of the lumbar spine with
spondylolisthesis: case report and review of the literature. Eur Spine J. 2010
Jul;19(Suppl 2):S153-7. Epub 2009 Nov 26.
19. Zemmoura I, Hamlat A, Morandi X. Intradural extramedullary spinal inflamma-
tory myofibroblastic tumor: case report and literature review. Eur Spine J. 2011
Jul;20(Suppl 2):S330-5. Epub 2011 Apr 06.
20. Roberts GA, Eldridge PR, Mackenzie JM. Case report: inflammatory pseudo-
tumour of the spine, with literature review. Br J Neurosurg. 1997 Dec;11(6):
570-2.
21. Piwowar HA, Day RS, Fridsma DB. Sharing detailed research data is associated
with increased citation rate. PLoS One. 2007;2(3):e308. Epub 2007 Mar 21.
22. Fletcher CDM, Unni KK, Mertens F. Pathology & genetics of tumours of soft
tissue and bone. Lyon, IARC; 2002. Inflammatory myofibroblastic tumour; p 91-93.
23. Butrynski JE, D’Adamo DR, Hornick JL, Dal Cin P, Antonescu CR, Jhanwar SC,
Ladanyi M, Capelletti M, Rodig SJ, Ramaiya N, Kwak EL, Clark JW, Wilner KD,
Christensen JG, Ja¨nne PA, Maki RG, Demetri GD, Shapiro GI. Crizotinib in ALK-
rearranged inflammatory myofibroblastic tumor. N Engl J Med. 2010 Oct
28;363(18):1727-33.
5
JBJS CASE CONNECTOR
VOLUME 3 d NUMBER 2 d MAY 8, 2013
INTRAOSSEOUS INFLAMMATORY MYOF IBROBLAST IC TUMOR
OF THE TWELFTH THORACIC VERTEBRA
